Freezing in Parkinson's Disease
parkinson
The Effect of Visual and Auditory Cueing Walker on Gait in Individuals With Parkinson's Disease Experiencing Freezing of Gait
2 other identifiers
interventional
30
1 country
2
Brief Summary
The aim of this study was to investigate the effects of a visual and auditory cueing walker on freezing of gait during walking in patients with Parkinson\'s disease (PDF), compared to Parkinson patients without freezing of gait (PDNF).Sample size was calculated to detect a difference of 0.37 m/sec on mean velocity, with a deviation of 0.3 m/sec, two-sided 5% significance level, and power of 90%. Considering the expected 10% dropout rate, twelve subjects were included.Researcher R1 determined whether the subject was eligible for inclusion in the trial and researcher R2 carried out the gait analysis. Both examiners were unaware of group allocation. An independent researcher (R3) performed the clinical evaluation before the procedures started. Participants walked back and forth on a 7-meter walking path under two different conditions: without cues and with a walker providing visual and auditory cues. To assess the risk of falls in both groups, the \"Tinetti Balance and Gait Assessment\" was conducted. Additionally, the \"Dynamic Gait Index\" was used to evaluate the ability to adapt walking to varying task demands, and the Timed Up and Go Test (TUGT) was employed to determine walking speed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Jun 2023
Shorter than P25 for not_applicable parkinson-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2023
CompletedFirst Submitted
Initial submission to the registry
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 8, 2025
CompletedOctober 8, 2025
September 1, 2025
4 months
September 30, 2025
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait Adaptation
Dynamic Gait Index: Time taken by the participant to complete the 7-meter walking path under each condition (without cues and with visual \& auditory cueing walker), measured using the Timed Up and Go Test (TUGT).
Immediately after walking with the visual and auditory cueing walker test was completed
Study Arms (2)
PDF (Parkinson's Disease with Freezing of Gait)
EXPERIMENTALIntervention Name: Visual \& Auditory Cueing Walker Description: "Participants in this arm were assessed under two within-subject conditions: walking on a 7-meter path without cues (control condition) and walking on the same path using a visual and auditory cueing walker (intervention condition). Each participant completed both conditions in a single session. Pre- and post-walking evaluations were conducted for walking speed (Timed Up and Go Test), fall risk (Tinetti Balance and Gait Assessment), and gait adaptation (Dynamic Gait Index). The 'no cues' condition represents a repeated-measures control within the same arm. Participants were included based on the presence of freezing of gait." Planned Enrollment: 18
PDNF (Parkinson's Disease without Freezing of Gait)
EXPERIMENTALIntervention Name: Visual \& Auditory Cueing Walker Description: "Participants in this arm were assessed under two within-subject conditions: walking on a 7-meter path without cues (control condition) and walking on the same path using a visual and auditory cueing walker (intervention condition). Each participant completed both conditions in a single session. Pre- and post-walking evaluations were conducted for walking speed (Timed Up and Go Test), fall risk (Tinetti Balance and Gait Assessment), and gait adaptation (Dynamic Gait Index). The 'no cues' condition represents a repeated-measures control within the same arm. Participants were included based on the absence of freezing of gait." Planned Enrollment: 12
Interventions
Intervention Name: Visual \& Auditory Cueing Walker Other Intervention Names (varsa): Cueing Walker Walker with Visual \& Auditory Cues Intervention Description: "Participants in this arm were assessed under two within-subject conditions: walking on a 7-meter path without cues (control condition) and walking on the same path using a visual and auditory cueing walker (intervention condition). Each participant completed both conditions in a single session. Pre- and post-walking evaluations were conducted for walking speed (Timed Up and Go Test), fall risk (Tinetti Balance and Gait Assessment), and gait adaptation (Dynamic Gait Index). The 'no cues' condition represents a repeated-measures control within the same arm. Participants were included based on the presence of freezing of gait." Planned Enrollment: 18
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Nezahat Keleşoğlu Faculty of Health Sciences
Konya, Meram, 40336, Turkey (Türkiye)
Necmettin Erbakan University
Konya, Meram, 40690, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
September 30, 2025
First Posted
October 8, 2025
Study Start
June 10, 2023
Primary Completion
October 10, 2023
Study Completion
December 10, 2023
Last Updated
October 8, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to participant privacy and confidentiality concerns, as well as institutional regulations governing sensitive patient information.